These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 17000745)
1. General catalytic deficiency of hepatitis C virus RNA polymerase with an S282T mutation and mutually exclusive resistance towards 2'-modified nucleotide analogues. Dutartre H; Bussetta C; Boretto J; Canard B Antimicrob Agents Chemother; 2006 Dec; 50(12):4161-9. PubMed ID: 17000745 [TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of a thumb domain hepatitis C virus nonnucleoside RNA-dependent RNA polymerase inhibitor. Howe AY; Cheng H; Thompson I; Chunduru SK; Herrmann S; O'Connell J; Agarwal A; Chopra R; Del Vecchio AM Antimicrob Agents Chemother; 2006 Dec; 50(12):4103-13. PubMed ID: 16940072 [TBL] [Abstract][Full Text] [Related]
3. The novel nucleoside analog R1479 (4'-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture. Klumpp K; Lévêque V; Le Pogam S; Ma H; Jiang WR; Kang H; Granycome C; Singer M; Laxton C; Hang JQ; Sarma K; Smith DB; Heindl D; Hobbs CJ; Merrett JH; Symons J; Cammack N; Martin JA; Devos R; Nájera I J Biol Chem; 2006 Feb; 281(7):3793-9. PubMed ID: 16316989 [TBL] [Abstract][Full Text] [Related]
4. Effects of mutations of the initiation nucleotides on hepatitis C virus RNA replication in the cell. Cai Z; Liang TJ; Luo G J Virol; 2004 Apr; 78(7):3633-43. PubMed ID: 15016884 [TBL] [Abstract][Full Text] [Related]
5. Specificity and mechanism analysis of hepatitis C virus RNA-dependent RNA polymerase. Johnson RB; Sun XL; Hockman MA; Villarreal EC; Wakulchik M; Wang QM Arch Biochem Biophys; 2000 May; 377(1):129-34. PubMed ID: 10775451 [TBL] [Abstract][Full Text] [Related]
6. A relaxed discrimination of 2'-O-methyl-GTP relative to GTP between de novo and Elongative RNA synthesis by the hepatitis C RNA-dependent RNA polymerase NS5B. Dutartre H; Boretto J; Guillemot JC; Canard B J Biol Chem; 2005 Feb; 280(8):6359-68. PubMed ID: 15561709 [TBL] [Abstract][Full Text] [Related]
7. Identification of a novel resistance mutation for benzimidazole inhibitors of the HCV RNA-dependent RNA polymerase. Delang L; Froeyen M; Herdewijn P; Neyts J Antiviral Res; 2012 Jan; 93(1):30-8. PubMed ID: 22033247 [TBL] [Abstract][Full Text] [Related]
8. De novo initiation pocket mutations have multiple effects on hepatitis C virus RNA-dependent RNA polymerase activities. Ranjith-Kumar CT; Sarisky RT; Gutshall L; Thomson M; Kao CC J Virol; 2004 Nov; 78(22):12207-17. PubMed ID: 15507607 [TBL] [Abstract][Full Text] [Related]
9. Resistance to nucleotide analogue inhibitors of hepatitis C virus NS5B: mechanisms and clinical relevance. Götte M Curr Opin Virol; 2014 Oct; 8():104-8. PubMed ID: 25128987 [TBL] [Abstract][Full Text] [Related]
10. A homogeneous, solid-phase assay for hepatitis C virus RNA-dependent RNA polymerase. Wang YK; Rigat KL; Roberts SB; Gao M Anal Biochem; 2006 Dec; 359(1):106-11. PubMed ID: 17054898 [TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of mutations conferring resistance to an HCV RNA-dependent RNA polymerase inhibitor in vitro. Lu L; Dekhtyar T; Masse S; Pithawalla R; Krishnan P; He W; Ng T; Koev G; Stewart K; Larson D; Bosse T; Wagner R; Pilot-Matias T; Mo H; Molla A Antiviral Res; 2007 Oct; 76(1):93-7. PubMed ID: 17561278 [TBL] [Abstract][Full Text] [Related]
12. Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase. Watashi K; Ishii N; Hijikata M; Inoue D; Murata T; Miyanari Y; Shimotohno K Mol Cell; 2005 Jul; 19(1):111-22. PubMed ID: 15989969 [TBL] [Abstract][Full Text] [Related]
13. Biochemical and pre-steady-state kinetic characterization of the hepatitis C virus RNA polymerase (NS5BDelta21, HC-J4). Cramer J; Jaeger J; Restle T Biochemistry; 2006 Mar; 45(11):3610-9. PubMed ID: 16533043 [TBL] [Abstract][Full Text] [Related]
14. Discovery of Novel Nucleotide Prodrugs with Improved Potency Against HCV Variants Carrying NS5B S282T Mutation. Zhen L; Dai L; Wen X; Yao L; Jin X; Yang XW; Zhao W; Yu SQ; Yuan H; Wang G; Sun H J Med Chem; 2017 Jul; 60(14):6077-6088. PubMed ID: 28650160 [TBL] [Abstract][Full Text] [Related]
15. Substrate selectivity of Dengue and Zika virus NS5 polymerase towards 2'-modified nucleotide analogues. Potisopon S; Ferron F; Fattorini V; Selisko B; Canard B Antiviral Res; 2017 Apr; 140():25-36. PubMed ID: 28041959 [TBL] [Abstract][Full Text] [Related]
16. Pyrophosphorolytic excision of nonobligate chain terminators by hepatitis C virus NS5B polymerase. Deval J; Powdrill MH; D'Abramo CM; Cellai L; Götte M Antimicrob Agents Chemother; 2007 Aug; 51(8):2920-8. PubMed ID: 17502402 [TBL] [Abstract][Full Text] [Related]
18. Assembly, purification, and pre-steady-state kinetic analysis of active RNA-dependent RNA polymerase elongation complex. Jin Z; Leveque V; Ma H; Johnson KA; Klumpp K J Biol Chem; 2012 Mar; 287(13):10674-10683. PubMed ID: 22303022 [TBL] [Abstract][Full Text] [Related]
19. A mutant of Sindbis virus which is able to replicate in cells with reduced CTP makes a replicase/transcriptase with a decreased Km for CTP. Li ML; Lin YH; Simmonds HA; Stollar V J Virol; 2004 Sep; 78(18):9645-51. PubMed ID: 15331697 [TBL] [Abstract][Full Text] [Related]
20. Use of 2'-spirocyclic ethers in HCV nucleoside design. Du J; Chun BK; Mosley RT; Bansal S; Bao H; Espiritu C; Lam AM; Murakami E; Niu C; Micolochick Steuer HM; Furman PA; Sofia MJ J Med Chem; 2014 Mar; 57(5):1826-35. PubMed ID: 24079820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]